Logo Logo

Category Archives: "Partners"

  1. Home
  2. Partners
  3. Page 3
Jun 15, 2021
MRI in Multiple Sclerosis Guidelines Update: North America, Europe align on new recommendations
Partners
These consensus guidelines are significant not only for their key updates to clinical practice but for their representation of a more [...]
Elizabeth Porco
Read More
...44
0
Jun 10, 2021
Congratulations to Dr. Robert Lisak: recipient of ANA’s Distinguished Neurology Teacher Award
MS Community, Partners
The CMSC Board, staff, and members would like to congratulate Dr. Robert Lisak for his selection as a recipient of the 2021 Distinguished [...]
Elizabeth Porco
Read More
...32
0
May 07, 2021
Study on cognitive processing speed changes in RMS subjects treated with Ozanimod
INforMS, Partners
Bristol Myers Squibb is conducting a Phase 3b Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing [...]
Elizabeth Porco
Read More
...33
0
Apr 16, 2021
New data for Ocrevus disease progression (ocrelizumab) reinforce significant slowing
INforMS, Partners
– 85% of treatment-naïve, early-stage relapsing-remitting multiple sclerosis (RRMS) patients achieved no evidence of disease activity [...]
Elizabeth Porco
Read More
...30
0
Apr 07, 2021
New Genentech data at 2021 AAN highlight impact & breadth of neuroscience portfolio
INforMS, Partners
Evrysdi (risdiplam) 2-year FIREFISH Part 2 data show improvement in motor function in infants with Type 1 spinal muscular atrophy [...]
Elizabeth Porco
Read More
...33
0
Mar 19, 2021
Janssen announces U.S. FDA approval of PONVORY™ (ponesimod)
INforMS, Partners
Head-to-head pivotal clinical trial results showed PONVORY™ treatment led to nearly a third fewer annual relapses than [...]
Elizabeth Porco
Read More
...33
0
Mar 08, 2021
NeurologyLive® & the CMSC launches MS Cure Connections® Video Series
CMSC PR, Partners
A diverse panel including an expert neurologist, a psychologist, a patient, and a care partner discuss the patient's journey with [...]
Elizabeth Porco
Read More
...35
0
Feb 02, 2021
FDA approval of intramuscular Plegridy (Peginterferon beta-1a)
INforMS, Partners
Please be advised  of the recent approval by the FDA for intramuscular Plegridy (Peginterferon beta-1a) and an update to other sections [...]
Elizabeth Porco
Read More
...31
0
Aug 24, 2020
Genentech’s enspryng for Neuromyelitis Optica Spectrum Disorder
INforMS, Partners
First and only FDA-approved subcutaneous treatment option for anti-aquaporin-4 antibody positive NMOSD that can be self-administered by a [...]
Elizabeth Porco
Read More
...38
0
Aug 19, 2020
Mylan brings critical access to the multiple sclerosis community
INforMS, MS Community, Partners
HERTFORDSHIRE, England, and PITTSBURGH– August 19, 2020 – Mylan N.V. (NASDAQ: MYL) today announced the launch of the first [...]
Elizabeth Porco
Read More
...36
0
  • (201) 487-1050
  • 3 University Plz Dr Ste 116, Hackensack, NJ 07601
  • info@mscare.org

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM